Officials Cut Corners with Biotech Crop Permits in Hawaii

Typography
A federal judge has ruled that U.S. agriculture officials violated environmental laws in permitting four companies to plant genetically modified crops in Hawaii to produce experimental drugs.

HONOLULU — A federal judge has ruled that U.S. agriculture officials violated environmental laws in permitting four companies to plant genetically modified crops in Hawaii to produce experimental drugs.


The order involves plantings of corn or sugarcane on Kauai, Maui, Molokai and Oahu between 2001 and 2003.


U.S. District Judge Michael Seabright said the Department of Agriculture's Animal and Plant Health Inspection Service flouted both the Endangered Species Act and National Environmental Policy Act by not conducting preliminary environmental reviews before issuing the planting permits.


The islands are home to 329 rare species -- a quarter of all threatened and endangered species in the nation, the judge noted in the order issued late last week.


Even if the inspection service is correct in its assertion that no habitats or species listed as endangered were harmed by the plantings, the agency's actions still are "tainted" because it failed to comply with a basic procedural requirement, Seabright said.


EarthJustice, which represents plaintiffs in the cases, said in a news release Monday that the decision is the first federal court ruling involving biofarming.


Rachel Iadicicco, a spokeswoman for the Animal and Plant Health Inspection Service, said the agency can't comment on pending litigation but has established procedures to guide it in complying with federal environmental laws.


The four companies issued the permits were ProdiGene, Monsanto, Hawaii Agriculture Research Center and Garst Seed. All of the companies' plants used to make pharmaceutical crops already have been harvested and the companies have stopped planting the crops under the permits.


The practice of using genetically engineered food crops to produce proteins that can be turned into medicines has faced growing opposition from farmers, environmentalists and big-time corporate food interests whose businesses might be affected by crop contamination.


Concerns center around the fear that the altered crops will crossbreed with conventional crops and thereby make it on to the plates of unknowing consumers. But there is also the concern that such crops could hurt local endangered species.


In his order, Seabright said the service skipped the mandatory step under the Endangered Species Act of gathering information about local listed species and critical habitats. The National Environmental Policy Act also requires federal agencies to evaluate the impact of their actions on the environment.


Both sides of the case have been ordered to appear in court on Aug. 22 to discuss remedies for the violations.


Source: Associated Press


Contact Info:


Website :